studies
incidence
sensory axonal neuropathy
patients
treated with
doses
thalidomide
study's
measure
variations
sural nerve sensory action potential
SAP
amplitude
patients
refractory cutaneous lupus erythematosus
CLE
treated with
thalidomide
findings
neurotoxic
potential
thalidomide
recovery
capacity
sensory fibres
discontinuation
treatment
